1. Home
  2. TNK vs SUPN Comparison

TNK vs SUPN Comparison

Compare TNK & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Teekay Tankers Ltd.

TNK

Teekay Tankers Ltd.

HOLD

Current Price

$99.52

Market Cap

2.5B

ML Signal

HOLD

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$40.74

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TNK
SUPN
Founded
2007
2005
Country
Bermuda
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.5B
IPO Year
2007
2010

Fundamental Metrics

Financial Performance
Metric
TNK
SUPN
Price
$99.52
$40.74
Analyst Decision
Buy
Buy
Analyst Count
5
4
Target Price
★ $96.80
$60.50
AVG Volume (30 Days)
354.5K
★ 737.9K
Earning Date
11-06-2026
10-29-2026
Dividend Yield
★ 1.05%
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $392,755,000.00
Revenue This Year
$14.17
$22.95
Revenue Next Year
N/A
$54.39
P/E Ratio
$8.05
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$50.94
$37.54
52 Week High
$110.65
$59.68

Technical Indicators

Market Signals
Indicator
TNK
SUPN
Relative Strength Index (RSI) 53.35 44.54
Support Level $71.28 $40.51
Resistance Level $103.16 $52.30
Average True Range (ATR) 3.61 1.82
MACD -1.03 0.04
Stochastic Oscillator 37.85 54.13

Price Performance

Historical Comparison
TNK
SUPN

About TNK Teekay Tankers Ltd.

Teekay Tankers Ltd is a provider of marine services to the international oil and natural gas industries and an operator of medium-sized oil tankers. The company operates in two segments: Tankers, which consists of the operation of all of the company's tankers (including the operations from those tankers employed on full service lightering contracts), and the company's U.S. based ship-to-ship support service operations (including its lightering support services provided as part of full service lightering operations); and Marine Services, which consists of operational and maintenance marine services provided to the Australian government, Australian energy companies and other third parties. The company generates the majority of its revenue from the Tankers segment.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.

Share on Social Networks: